Literature DB >> 31654273

No Association Between AKT1 Polymorphisms and Methamphetamine Addiction in Iranian Population.

Soudeh Ghafouri-Fard1, Iman Azari1, Fatemeh Hashemian1, Azim Nejatizadeh2, Mohammad Taheri3.   

Abstract

Previous studies have shown a high level of heritability for most kinds of substance abuse. Certain single nucleotide polymorphisms (SNPs) or haplotypes have been shown to influence methamphetamine abuse or the related psychosis. Among the most related pathways in dependence to methamphetamine are dopaminergic system-related genes especially V-akt murine thymoma viral oncogene homolog 1 (AKT1). In the current investigation, we genotyped two intronic variants within the AKT1 gene (rs2494743 and rs2498794) in a population of Iranian methamphetamine-dependent individuals and controls. There were no significant differences in alleles, genotypes, or haplotype frequencies of rs2494743 and rs2498794 between cases and controls. Consequently, our study excludes participation of these SNPs in susceptibility to methamphetamine dependence. However, other variants within this gene might affect this trait, so future studies are needed to assess associations between other AKT1 variants and methamphetamine dependence.

Entities:  

Keywords:  AKT1; Methamphetamine; rs2494743; rs2498794

Year:  2019        PMID: 31654273     DOI: 10.1007/s12031-019-01413-w

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population.

Authors:  T Ohtsuki; T Inada; T Arinami
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

2.  Association of AKT1 with schizophrenia confirmed in a Japanese population.

Authors:  Masashi Ikeda; Nakao Iwata; Tatsuyo Suzuki; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Toshiya Inada; Norio Ozaki
Journal:  Biol Psychiatry       Date:  2004-11-01       Impact factor: 13.382

3.  Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins.

Authors:  K S Kendler; L Karkowski; C A Prescott
Journal:  Acta Psychiatr Scand       Date:  1999-05       Impact factor: 6.392

4.  Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

Authors:  Masayuki Ide; Tetsuo Ohnishi; Miyuki Murayama; Izuru Matsumoto; Kazuo Yamada; Yoshimi Iwayama; Irina Dedova; Tomoko Toyota; Takashi Asada; Akihiko Takashima; Takeo Yoshikawa
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

5.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

6.  Positive association of AKT1 haplotype to Japanese methamphetamine use disorder.

Authors:  Masashi Ikeda; Nakao Iwata; Tatsuyo Suzuki; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshiya; Yoshimoto Sekine; Masaomi Iyo; Mutsuo Harano; Tokutaro Komiyama; Mitsuhiko Yamada; Ichiro Sora; Hiroshi Ujike; Toshiya Inada; Norio Ozaki
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-28       Impact factor: 5.176

7.  Genetic and environmental risk factors for illicit substance use and use disorders: Joint analysis of self and co-twin ratings.

Authors:  Eivind Ystrom; Ted Reichborn-Kjennerud; Michael C Neale; Kenneth S Kendler
Journal:  Behav Genet       Date:  2013-11-07       Impact factor: 2.805

8.  A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.

Authors:  Zhihua Xie; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2009-04-13       Impact factor: 4.030

9.  Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Authors:  George R Uhl; Tomas Drgon; Qing-Rong Liu; Catherine Johnson; Donna Walther; Tokutaro Komiyama; Mutsuo Harano; Yoshimoto Sekine; Toshiya Inada; Norio Ozaki; Masaomi Iyo; Nakao Iwata; Mitsuhiko Yamada; Ichiro Sora; Chih-Ken Chen; Hsing-Cheng Liu; Hiroshi Ujike; Shih-Ku Lin
Journal:  Arch Gen Psychiatry       Date:  2008-03

10.  Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers.

Authors:  Hiroki Koizumi; Kenji Hashimoto; Chikara Kumakiri; Eiji Shimizu; Yoshimoto Sekine; Norio Ozaki; Toshiya Inada; Mutsuo Harano; Tokutaro Komiyama; Mitsuhiko Yamada; Ichiro Sora; Hiroshi Ujike; Nori Takei; Masaomi Iyo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-04-01       Impact factor: 3.568

View more
  1 in total

Review 1.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.